Kanker prostat adalah kanker paleng umum keudua bak ureung agam di donya, deungon kira-kira 1.276 juta kasus baro nyang dilapor bak thon 2018, nyang mewakili 7,1% dari mandum kasus kanker bak ureung agam.
Tingkat kematian untuk kanker prostat cit tinggi, deungon perkiraan 37.005 kematian di seluruh donya bak thon 2018.
Namun, tingkat kematian bervariasi that menurut wilayah, deungen Afrika Barat na risiko keulimong paleng rayek untuk kematian kanker prostat di donya, dan Nigeria na populasi dan ekonomi paleng rayek di wilayah nyoe.
Di Nigeria, kanker prostat adalah kanker nyang paleng umum ngon paleng mematikan bagi ureung agam, deungen perkiraan 32,8 kasus ngon 16,3 kematian per 100.000 ureung agam.
Nyo leubeh dari dua kali lipat tingkat kematian di Amerika Utara.
Deteksi panyang peunyaket, sumber daya terbatas untuk skrining dan deteksi, dan penurunan dokumentasi dan pelaporan kasus berkontribusi bak tingkat kematian yang tinggi di Nigeria.
Di Amerika Serikat, kanker prostat adalah penyebab paleng umum keudua kematian kanker bak ureung agam, deungen kira-kira 40.000 ureung agam meuninggai dari peunyaket nyoe tiep thon.
Tingkat kematian kanker prostat ka meukureung bacut-bacut sejak awai 1990-an, tapi teutap jeut keu masalah kesehatan yang signifikan.
Secara umum, kanker prostat adalah peunyaket mematikan, terutama di wilayah yang terbatas akses ke perawatan medis dan sumber daya skrining.
Namun, deteksi dan perawatan awai jeut ji tingkatkan hasee ngon ji kurangi tingkat kematian.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Peuneugah: medis']
['Situs web nyoe hanya dipeutaba untuk tujuan pendidikan dan informasi dan hana merupakan nasehat medis atau layanan profesional.']
['Informasi nyang geubri hana jeut dipakek untuk mendiagnosis atau meuobati masalah kesehatan atau peunyaket, dan awak nyang mita nasehat medis pribadi harus berkonsultasi deungen dokter berlisensi.']
['Neuronal net nyang ji peuhase jawaban keu pertanyaan, khusus jih hana akurat wate ji peugah tentang konten numerik. miseu jih, jumlah ureung nyang ji diagnosa deungen peunyaket tertentu.']
['Sabe-sabe mita saran dari dokter atau penyedia kesehatan laen nyang berkualitas teuntang kondisi medis. Han tom neutilek nasihat medis profesional atawa neuterlambat mita jih kareuna na sesuatu nyang kaleuh neubaca bak situs web nyoe. Meunyo droeneuh pike droeneuh na darurat medis, hubungi 911 atawa neujak u ruang gawat darurat paleng toe langsong. Hana hubungan dokter-pasien nyang dipeuget le situs web nyoe atawa penggunaan jih. BioMedLib maupun karyawan jih, atawa kontributor situs web nyoe, hana dipeuget representasi, nyata atawa tersirat, teuntang informasi nyang geubri disinoe atawa penggunaan jih.']
['Peuneugah: hak cipta']
['Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) geubi recourse keu ureung po hak cipta nyang yakin bahwa materi nyang deuh bak internet ji langgar hak awak nyan di miyup undang-undang hak cipta AS. ']
['Meunyo droeneuh yakin ngon get bahwa asoe atawa bahan nyang geupeutamöng lam hubôngan ngon website atawa layanan kamoe meulangga hak cipta droeneuh, droeneuh (atawa agen droeneuh) jeuet neukirém beuneuri keu kamoe ngön neulakèe mangat asoe atawa bahan nyan geusampôh, atawa geupeublok akses keujih.']
['Peumaklum haroh dikirim seucara tuleh deungen email (nging bagian "Kontak" untuk alamat email).']
['DMCA peurlee bahwa bewara droeneuh teuntang dugaan pelanggaran hak cipta teumasok informasi berikut: (1) deskripsi karya yang dilindungi hak cipta yang merupakan subjek klaim pelanggaran; (2) deskripsi konten yang diduga melanggar dan informasi yang cukup untuk memungkinkan kamoe untuk meutumeng konten; (3) informasi kontak untuk droeneuh, termasuk alamat, nomor telepon dan alamat email droeneuh; (4) pernyataan droeneuh bahwa droeneuh yakin bahwa konten yang diklaim hana diizinkan le pemilik hak cipta, atau agen jih, atau oleh operasi hukum apapun; ']
['(5) saboh pernyataan dari droeneuh, yang diteken deungen hukuman sumpah palsu, bahwa informasi lam pemberitahuan nyan akurat dan bahwa droeneuh na wewenang untuk menegakkan hak cipta yang diklaim dilanggar;']
['dan (6) tanda jaroe fisik atawa elektronik dari nyang po hak cipta atawa sidroe ureng nyang berwenang untuk bertindak atas nama nyang po hak cipta. ']
['Meunye hana neupeutamong mandum informasi di ateuh jeut keu akibat teulat meungurus keluhan droeneuh.']
['Kontak']
['Neukirem kheueh email keukamoe ateuh peue-peue nyang neutanyong atawa saran.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Teuntang']
['BioMedLib ji pakek komputer otomatis (algoritma pembelajaran meusen) untuk ji peuget pasangan pertanyaan ngen jawaban.']
['Kamoe mulai deungen 35 juta publikasi biomedis PubMed/Medline. Meunan sit, halaman web RefinedWeb.']
